PHAT · NASDAQ · Biotechnology

Phathom Pharmaceuticals (PHAT)

Brings Takeda's vonoprazan acid blocker to U.S. patients under the VOQUEZNA brand.

$7.08
vs last close−0.69 (−8.83%)